GINKGO BIOWORKS HOLDINGS, INC. Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount of $2.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Annual Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount · last filed 2026-02-26
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2025-09-30 was $2.71M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2025-06-30 was $229.00K, a 88.11% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2025-03-31 was $1.85M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2025 was $2.71M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2023 was $1.63M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2022 was $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 9 month as first filed | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $2.71M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $2.71M 10-Q · filed 2025-11-06 | $2.71M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $229.00K 10-Q · filed 2025-08-07 | $2.08M 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | $1.85M 10-Q · filed 2025-05-06 | ||||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $1.93M 10-Q · filed 2025-08-07 | ||||
| 2023-12-31 | $1.63M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $1.63M 10-Q · filed 2024-11-12 | $1.63M 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2023-11-08 | ||
| 2023-06-30 | $2.12M 10-Q · filed 2024-08-08 | $6.68M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $4.56M 10-Q · filed 2024-05-09 | ||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-25 | ||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |